News Releases
Mar 29, 2023
Lyra Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
Additional Formats
Feb 27, 2023
Lyra Therapeutics Announces Appointment of John Bishop, Ph.D., as Chief Technology Officer
Additional Formats
Feb 06, 2023
Lyra Therapeutics Announces Completion of Enrollment in the BEACON Phase 2 Clinical Trial of LYR-220 in Post-Surgical Chronic Rhinosinusitis Patients
Additional Formats
Jan 17, 2023
Lyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Additional Formats